Perturbed liver gene zonation in a mouse model of non-alcoholic steatohepatitis.

In situ hybridization Liver zonation Non-alcoholic steatohepatitis Rspo3 Spatial transcriptomics Wnt

Journal

Metabolism: clinical and experimental
ISSN: 1532-8600
Titre abrégé: Metabolism
Pays: United States
ID NLM: 0375267

Informations de publication

Date de publication:
28 Feb 2024
Historique:
received: 29 10 2023
revised: 23 02 2024
accepted: 24 02 2024
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

Liver zonation characterizes the separation of metabolic pathways along the lobules and is required for optimal hepatic function. Wnt signaling is a master regulator of spatial liver zonation. A perivenous-periportal Wnt activity gradient orchestrates metabolic zonation by activating gene expression in perivenous hepatocytes, while suppressing gene expression in their periportal counterparts. However, the understanding as to the liver gene zonation and zonation regulators in diseases is limited. Non-alcoholic steatohepatitis (NASH) is a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis. Here, we investigated the perturbation of liver gene zonation in a mouse NASH model by combining spatial transcriptomics, bulk RNAseq and in situ hybridization. Wnt-target genes represented a major subset of genes showing altered spatial expression in the NASH liver. The altered Wnt-target gene expression levels and zonation spatial patterns were in line with the up regulation of Wnt regulators and the augmentation of Wnt signaling. Particularly, we found that the Wnt activator Rspo3 expression was restricted to the perivenous zone in control liver but expanded to the periportal zone in NASH liver. AAV8-mediated RSPO3 overexpression in controls resulted in zonation changes, and further amplified the disturbed zonation of Wnt-target genes in NASH, similarly Rspo3 knockdown in Rspo3

Identifiants

pubmed: 38428673
pii: S0026-0495(24)00056-8
doi: 10.1016/j.metabol.2024.155830
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155830

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: All authors are or were employees and shareholders of Regeneron Pharmaceuticals. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ye Zhou (Y)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Yuanqi Zhao (Y)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Marisa Carbonaro (M)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Helen Chen (H)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Mary Germino (M)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Christina Adler (C)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Min Ni (M)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Yuan O Zhu (YO)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Sun Y Kim (SY)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Judith Altarejos (J)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Zhe Li (Z)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Michael E Burczynski (ME)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

David J Glass (DJ)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Mark W Sleeman (MW)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Ann-Hwee Lee (AH)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Gabor Halasz (G)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America.

Xiping Cheng (X)

Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, United States of America. Electronic address: xiping.cheng@regeneron.com.

Classifications MeSH